Presentations we supply
- Injection 100 mg
Tell us whether you need the originator brand or a generic, the strength, pack and quantity, and the destination country.
Send Enquiry for PembrolizumabReference information
Summarised from the product information for Keytruda. Always follow the product information approved in your own country.
- Active substance
- Pembrolizumab
- Pharmacotherapeutic group
- Antineoplastic agents, PD-1/PDL-1 (programmed cell death protein 1/death ligand 1) inhibitors (ATC code L01FF02)
- Authorised uses
- Advanced melanoma in adults and adolescents aged 12 years and older
- Adjuvant treatment of stage IIB, IIC or III melanoma after complete resection
- Non-small cell lung cancer, including neoadjuvant, adjuvant and first-line use
- Relapsed or refractory classical Hodgkin lymphoma in adults and children aged 3 years and older
- Urothelial carcinoma, including first-line use
- Head and neck squamous cell carcinoma with PD-L1 CPS of 1 or more
- Renal cell carcinoma, first-line combinations and adjuvant use
- MSI-H or dMMR colorectal cancer and other MSI-H or dMMR tumours
- Triple-negative breast cancer, early and metastatic disease
- Other indications listed in section 4.1 of the product information
- Storage (unopened)
- Store in a refrigerator (2 °C to 8 °C). Do not freeze. Store in the original carton in order to protect from light.
- Shelf life (unopened)
- Concentrate for infusion (unopened vial): 2 years. Solution for subcutaneous injection (unopened vial): 3 years
- Container and pack
- Infusion: 4 ml (100 mg) in a 10 ml Type I glass vial, packs of 1 or 2. Subcutaneous: 2.4 ml (395 mg) or 4.8 ml (790 mg) vial, pack of 1
Supply from Bio Bridge Pharma
- The registration route and import licence are confirmed for your destination before we make an offer.
- Documents agreed before you order, such as the batch certificate of analysis and a CoPP where your regulator needs one.
- Cold-chain shipment for this refrigerated product.
- Named patient supply where the destination country's rules allow it.
Sources
- Product information for Keytruda: www.ema.europa.eu